Ketamine Beating Psilocybin in Race for Patients
With the state of Oregon's move to decriminalize drugs, the stigma around compounds like ketamine is lessening.
Zebra Technologies Could Correct in the Weeks Ahead
The shares have more than doubled from their March nadir.
Can These 2 Blue Chips Stocks Still Be Bargains After Just Surging Over 27%?
The short answer? Yes!
Trupanion Could Be the Cat's Meow for Investors
Here's what might happen next for shares of the pet insurance company.
Jim Cramer: Celebrating a Vaccine!
It's so huge. Hard to grasp. It's incredible.
CVS Is Aggressive and Optimistic, and I'm Long the Shares
The firm's Q3 earnings easily beat Wall Street's expectations.
Can UnitedHealth Group and Cigna Stay Healthy?
Let's see if UNH and CI are what the doctor ordered.
Teladoc Could Rally From Here
Is Teladoc's merger with Livongo Health a 'game changer' for the stock?
Humana's Charts Are Not as Healthy as We Would Like
The company is set to report earnings Tuesday.
Here's a Dividend Aristocrat Trading at a Discount
With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.